Fate Therapeutics (FATE) stock Forecast for 2021 – 2025

Fate Therapeutics (FATE) stock Forecast for 2022 – 2026

Last update: 05-20-2022, 10:40

Sector: Healthcare

The share price of Fate Therapeutics, Inc. (FATE) now

What analysts predict:: $86.26

52-week high/low: $97.43 / $20.49

50/200 Day Moving Average: $34.04 / $51.69

This figure corresponds to the average price over the previous 50/200 days. For Fate Therapeutics stocks, the 50-day moving average is the resistance level today.

For Fate Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Fate Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Fate Therapeutics stock price in 2022, 2023, 2024, 2025, 2026. How much will one Fate Therapeutics share be worth in 2022 - 2026?

When should I take profit in Fate Therapeutics stock? When should I record a loss on Fate Therapeutics stock? What are analysts' forecasts for Fate Therapeutics stock? What is the future of Fate Therapeutics stock?

We forecast Fate Therapeutics stock performance using neural networks based on historical data on Fate Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Fate Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Fate Therapeutics shares. This happens once a day.




Historical and forecast chart of Fate Therapeutics stock

The chart below shows the historical price of Fate Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Fate Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Fate Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
May 22 22.94 22.66 23.39 3.24
May 23 22.93 22.56 23.20 2.85
May 24 23.06 22.62 23.30 3.02
May 25 22.73 22.10 23.28 5.35
May 26 23.21 22.58 23.95 6.04
May 27 23.04 22.75 23.30 2.43
May 28 22.95 22.69 23.40 3.16
May 29 22.65 22.31 23.37 4.75
May 30 22.62 21.91 22.89 4.46
May 31 22.93 22.68 23.50 3.60
Jun 01 22.09 21.71 22.57 3.99
Jun 02 22.37 21.66 22.64 4.50
Jun 03 23.13 22.47 23.83 6.05
Jun 04 23.93 23.74 24.34 2.54
Jun 05 23.88 23.14 24.38 5.32
Jun 06 24.58 24.23 24.89 2.72
Jun 07 24.98 24.22 25.70 6.11
Jun 08 25.09 24.45 25.79 5.50
Jun 09 24.83 24.34 25.26 3.75
Jun 10 24.20 23.73 24.69 4.04
Jun 11 23.84 23.17 24.20 4.44
Jun 12 22.98 22.44 23.37 4.14
Jun 13 23.71 23.46 24.22 3.28
Jun 14 23.83 23.44 24.42 4.19
Jun 15 24.04 23.66 24.79 4.75
Jun 16 23.95 23.27 24.25 4.20
Jun 17 23.87 23.17 24.06 3.87
Jun 18 23.27 22.76 23.71 4.17
Jun 19 23.23 22.69 23.43 3.28
Jun 20 22.64 22.14 22.96 3.68

Fate Therapeutics Daily Price Targets


Fate Therapeutics Stock Forecast 05-22-2022.

Forecast target price for 05-22-2022: $22.94. Positive dynamics for Fate Therapeutics shares will prevail with possible volatility of 3.138%.

Pessimistic target level: 22.66

Optimistic target level: 23.39


Fate Therapeutics Stock Forecast 05-23-2022.

Forecast target price for 05-23-2022: $22.93. Negative dynamics for Fate Therapeutics shares will prevail with possible volatility of 2.767%.

Pessimistic target level: 22.56

Optimistic target level: 23.20


Fate Therapeutics Stock Forecast 05-24-2022.

Forecast target price for 05-24-2022: $23.06. Positive dynamics for Fate Therapeutics shares will prevail with possible volatility of 2.930%.

Pessimistic target level: 22.62

Optimistic target level: 23.30


Fate Therapeutics Stock Forecast 05-25-2022.

Forecast target price for 05-25-2022: $22.73. Negative dynamics for Fate Therapeutics shares will prevail with possible volatility of 5.078%.

Pessimistic target level: 22.10

Optimistic target level: 23.28


Fate Therapeutics Stock Forecast 05-26-2022.

Forecast target price for 05-26-2022: $23.21. Positive dynamics for Fate Therapeutics shares will prevail with possible volatility of 5.700%.

Pessimistic target level: 22.58

Optimistic target level: 23.95


Fate Therapeutics Stock Forecast 05-27-2022.

Forecast target price for 05-27-2022: $23.04. Negative dynamics for Fate Therapeutics shares will prevail with possible volatility of 2.372%.

Pessimistic target level: 22.75

Optimistic target level: 23.30


FATE (FATE) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 27.20 24.27 28.04 13.45
Jul. 30.78 28.37 33.20 14.54
Aug. 30.48 29.37 32.70 10.18
Sep. 31.72 29.94 32.61 8.17
Oct. 32.52 31.11 34.34 9.41
Nov. 35.43 32.80 36.47 10.06
Dec. 35.18 33.76 36.27 6.93

Fate Therapeutics forecast for this year


Fate Therapeutics Stock Prediction for Jun 2022

An uptrend is forecast for this month with an optimal target price of $27.2039. Pessimistic: $24.27. Optimistic: $28.04


Fate Therapeutics Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $30.7839. Pessimistic: $28.37. Optimistic: $33.20


Fate Therapeutics Stock Prediction for Aug 2022

An downtrend is forecast for this month with an optimal target price of $30.4823. Pessimistic: $29.37. Optimistic: $32.70


Fate Therapeutics Stock Prediction for Sep 2022

An uptrend is forecast for this month with an optimal target price of $31.7198. Pessimistic: $29.94. Optimistic: $32.61


Fate Therapeutics Stock Prediction for Oct 2022

An uptrend is forecast for this month with an optimal target price of $32.5192. Pessimistic: $31.11. Optimistic: $34.34


Fate Therapeutics Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $35.4329. Pessimistic: $32.80. Optimistic: $36.47


Fate Therapeutics Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $35.1849. Pessimistic: $33.76. Optimistic: $36.27




Fate Therapeutics (FATE) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 34.40 31.03 36.95 16.03
Feb 32.71 30.24 35.28 14.28
Mar 33.86 32.53 37.65 13.60
Apr 31.25 28.84 34.22 15.72
May 26.87 25.22 29.21 13.65
Jun 26.61 24.56 28.36 13.40
Jul 26.98 24.15 29.44 17.96
Aug 29.06 26.95 30.32 11.14
Sep 28.00 26.94 29.65 9.12
Oct 27.10 25.51 27.90 8.57
Nov 27.06 26.04 29.98 13.14
Dec 29.72 28.80 31.92 9.77

Fate Therapeutics (FATE) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 30.67 28.70 33.59 14.57
Feb 26.46 24.46 27.28 10.32
Mar 24.61 23.85 25.30 5.72
Apr 25.61 24.61 28.01 12.16
May 26.15 23.40 28.46 17.75
Jun 28.97 27.31 30.67 10.97
Jul 30.67 28.65 32.82 12.69
Aug 34.62 33.07 37.92 12.78
Sep 32.49 30.08 33.85 11.15
Oct 29.62 26.84 32.36 17.05
Nov 28.42 26.83 31.33 14.35
Dec 26.99 24.68 29.78 17.13



Fate Therapeutics (FATE) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 25.93 23.90 27.02 11.55
Feb 25.75 24.16 27.23 11.25
Mar 24.27 23.35 25.43 8.15
Apr 23.22 22.15 25.27 12.35
May 21.88 19.99 23.17 13.75
Jun 21.18 19.40 21.83 11.14
Jul 22.66 21.52 23.49 8.38
Aug 24.76 22.33 27.43 18.58
Sep 24.17 21.87 26.77 18.32
Oct 21.77 20.24 23.90 15.30
Nov 22.13 20.49 23.56 13.02
Dec 22.16 19.99 24.46 18.27

Fate Therapeutics (FATE) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 23.03 21.39 24.87 14.00
Feb 21.58 19.56 22.70 13.84
Mar 20.10 19.31 21.93 11.93
Apr 21.76 20.78 23.22 10.49
May 24.38 22.16 26.12 15.16
Jun 26.02 23.25 27.84 16.49
Jul 28.79 27.30 30.72 11.15
Aug 27.01 25.54 27.81 8.16
Sep 28.00 25.14 30.00 16.20
Oct 28.70 25.69 30.39 15.47
Nov 25.85 23.61 26.64 11.41
Dec 27.30 24.43 30.16 19.00

Fate Therapeutics information and performance

Fate Therapeutics, Inc. provides biopharmaceutical services. The company researches and develops therapies for the restoration and regeneration of body tissues using stem cells. The company operates in the USA.

Official website of the company

Fate Therapeutics Address

3535 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, US

Market Capitalization: 2 340 357 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -76 343 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.239

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 0.074

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 29.79

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 96629000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.